Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Nearly 500 Amgen Staffers to be Reassigned, Relocated or Laid Off in Restructuring

Up to 500 Amgen employees based at the company’s Thousand Oaks facilities will be relocated to a new site in Tampa, Fla. and other sites, or be terminated, over the next 18 months as part of a new restructuring plan.

Read More »

Johnson & Johnson’s $100,000 Anti-Burnout Program for Top Execs

Johnson & Johnson’s Human Performance Institute has developed a Premier Executive Leadership program to help executives avoid burnout.

Read More »

Chinese drug approval for AstraZeneca’s Tagrisso

AstraZeneca has won approval for its lung cancer pill Tagrisso in China, a key market for the potential blockbuster medicine.

Read More »

Trump tastes failure as U.S. House healthcare bill collapses

President Donald Trump suffered a stunning political setback in a Congress controlled by his own party when Republican leaders pulled legislation to overhaul the U.S. healthcare system, a major 2016 election campaign promise of the president and his allies.

Read More »

House clears way for debate on Trump-backed healthcare bill

The Republican-controlled U.S. House of Representatives cleared the way for a contentious debate on legislation to repeal Obamacare and replace it with a more limited federal healthcare insurance program.

Read More »

Pfizer Receives Positive CHMP Opinion for Trumenba for Prevention of Meningococcal Group B Disease

Pfizer Inc. today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending that Trumenba (Meningococcal Group B Vaccine) be granted marketing authorization in the European Union for active immunization of individuals 10 years and older to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B (MenB).

Read More »

EMA panel backs Novo Nordisk’s hemophilia B drug

A panel of the European Medicines Agency said it recommended granting marketing approval to Danish drugmaker Novo Nordisk’s hemophilia B drug.

Read More »

Why pressure is mounting for life sciences to take digital transformation seriously

Habit and red tape are not sufficient excuses for life sciences organizations to keep doing things the way they always have.

Read More »

Judge dismisses two Express Scripts claims

A federal judge dismissed two of the six counterclaims that Express Scripts raised in health insurer’s Anthem’s $15 billion lawsuit claiming it charged too much for drugs.

Read More »

Drugmaker Lilly to invest $850 million in U.S. operations in 2017

Eli Lilly and Co. said it would invest $850 million in its U.S. operations during 2017, and the drugmaker signaled it would be willing to spend more if the Trump administration were to overhaul tax laws.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom